Dog Body Surface Area BSA Chemotherapy Dose Calculator

Why BSA, Not Body Weight, for Chemo

In veterinary oncology, chemotherapy is dosed by body surface area (BSA) in m², not body weight in kg. Organ function (kidney, liver) correlates better with BSA than weight, especially across the wide size range of dog breeds (2 kg Chihuahua to 80 kg Mastiff).

The Formula

BSA (m²) = 0.101 × BW(kg)^(2/3)

Equivalently: (10.1 × BW(g)^(2/3)) / 10000

Questions This Calculator Answers

• “What is my dog’s body surface area?” – Calculated from body weight
• “Why is BSA used for chemo instead of weight?” – Better organ function correlation
• “What chemo doses are standard for dogs?” – Drug-specific ranges
• “What is the maximum vincristine dose?” – 1 mg total regardless of BSA (cap)
• “How do I adjust chemo dose for kidney disease?” – 15-50% reduction
• “What is the doxorubicin cumulative limit?” – 240 mg/m² total (lower in DCM breeds)
• “What is the CHOP protocol?” – Cyclophosphamide + Hydroxydaunorubicin + Oncovin + Prednisone
• “Is canine chemotherapy safe at home?” – Mostly given at vet; some oral chemo with safety protocols
• “What side effects should I watch for?” – Anorexia, vomiting, diarrhea, lethargy, fever

BSA Reference Table

Standard Canine Chemotherapy Doses

CHOP Protocol – Canine Lymphoma Standard

25-week multi-drug protocol for canine lymphoma:

Outcomes:

• Median survival 12-14 months vs untreated 2-3 months
• 80-90% remission rate
• Cost $5,000-8,000

Modified protocols (Madison-Wisconsin) common. Rescue protocols (MOPP, DMAC, lomustine) for relapse.

Critical Safety Considerations

Vincristine – 1 mg Absolute Cap

Universally accepted veterinary oncology limit. Never exceed 1 mg total regardless of calculated BSA dose.

Doxorubicin – Cardiac Cumulative Limit

• 240 mg/m² total for healthy dogs
• 180 mg/m² for DCM-prone breeds (Doberman, Boxer)
• ECG baseline + every other dose
• Switch to mitoxantrone if cardiac concerns

Cyclophosphamide – Hemorrhagic Cystitis Prevention

• Give in morning
• Furosemide 1-2 mg/kg PO at same time
• Free water access all day
• Frequent potty breaks
• Monitor urine for blood
• Switch to chlorambucil if cystitis develops

Extravasation – Tissue-Necrosing Emergency

Vincristine, vinblastine, doxorubicin all cause severe tissue necrosis if extravasated.

• Confirm IV placement before each push
• Extravasation kit ready (dexrazoxane antidote for doxorubicin within 6 hours)
• Cold compresses (NOT warm)

Neutropenia

• ANC nadir day 7-10 typically
• CBC pre-treatment + nadir + recovery
• Hold treatment if ANC < 2000 cells/µL
• Febrile neutropenia = EMERGENCY – hospitalize + broad-spectrum antibiotics

Hepatotoxicity (Lomustine)

• Liver panel before each dose
• Denamarin SAMe protectant
• Cap cumulative dose
• Monitor ALT/ALP every other dose

Dose Adjustments

Household Safety During Chemo

Chemo metabolites in urine and feces 48-72 hours post-treatment.

• Gloves + bag disposal of dog waste
• Wash hands after handling dog
• Pregnant or immunosuppressed household members – extra precautions
• Urine in toilet – flush twice
• Feces in plastic bag – sealed garbage
• Bedding cleaning post-elimination period
• Normal household interaction OK
• Dog’s saliva/sweat generally safe
• NOT transmissible to other pets via contact

Canine vs Human Chemotherapy

Veterinary Oncologist Referral

For confirmed cancer, Diplomate ACVIM Oncology referral dramatically improves outcomes.

• acvim.org Find a Specialist
• Specialty centers offer protocols not available at general practice
• Dose calculation expertise + safety monitoring
• Work with oncologist for any chemotherapy protocol

Conclusion

BSA-based dosing is the standard for canine chemotherapy because organ function correlates better with BSA than weight. BSA formula: 0.101 × BW(kg)^(2/3). CHOP protocol is canine lymphoma standard – 12-14 month median survival vs 2-3 untreated. Critical safety: vincristine 1 mg cap, doxorubicin 240 mg/m² cumulative, cyclophosphamide hemorrhagic cystitis prevention, extravasation prevention, neutropenia monitoring. Veterinary oncologist prescribes and administers – this calculator is reference only.

Frequently Asked Questions

What is BSA and why is it used for dog chemotherapy?

BODY SURFACE AREA (BSA) is the calculated surface area of the body in square meters (m²). FORMULA for dogs: BSA (m²) = 0.101 × body weight (kg)^(2/3); equivalently BSA = (10.1 × body weight grams^(2/3)) / 10000. WHY BSA INSTEAD OF WEIGHT for chemotherapy: 1) ORGAN FUNCTION (kidney, liver) correlates better with body surface area than body weight; 2) METABOLIC RATE follows allometric scaling proportional to body weight^0.75 – similar to BSA scaling; 3) CARDIAC OUTPUT, drug clearance, oxygen consumption all scale with surface area; 4) ACROSS HUGE SIZE RANGE of dog breeds (Chihuahua 2 kg to Mastiff 80 kg) BSA gives more consistent dosing than weight-based; 5) HUMAN ONCOLOGY uses same principle for same reasons. EXAMPLES of BSA vs body weight: 5 kg dog = 0.295 m² (~0.06 m²/kg); 25 kg dog = 0.864 m² (~0.035 m²/kg); ratio of BSA to BW decreases as dog gets larger – so SMALLER dogs proportionally get HIGHER chemo doses than would be predicted by weight alone. EXAMPLE – DOXORUBICIN at 30 mg/m²: 5 kg dog gets 8.85 mg (1.77 mg/kg); 25 kg dog gets 25.92 mg (1.04 mg/kg) – same effective biological dose at different mg/kg values. WEIGHT-BASED DOSING used for SOME drugs: 1) TOCERANIB (Palladia) 2.7-2.75 mg/kg M/W/F; 2) PIROXICAM 0.3 mg/kg q24h or q48h; 3) PREDNISONE 0.5-2 mg/kg/day; 4) CHLORAMBUCIL alternative dosing 0.1-0.2 mg/kg. ALL OTHER major chemo drugs in dogs use BSA: doxorubicin, vincristine, vinblastine, cyclophosphamide, carboplatin, cisplatin, lomustine, mitoxantrone, melphalan, chlorambucil (BSA OR weight). CALCULATION TIPS: 1) Use exact body weight (weighed not estimated); 2) Re-weigh before each treatment cycle; 3) Round calculated dose to practical volume (small dogs especially); 4) Vincristine 1 mg absolute cap regardless of BSA – smaller doses smaller BSA fine, larger doses larger BSA capped at 1 mg. WORK WITH VETERINARY ONCOLOGIST for proper dose calculation – this calculator provides reference values but actual treatment requires complete patient workup.

What is the CHOP protocol for dogs?

CHOP is the GOLD STANDARD CHEMOTHERAPY PROTOCOL for canine lymphoma. ACRONYM: C = Cyclophosphamide; H = Hydroxydaunorubicin (doxorubicin); O = Oncovin (vincristine); P = Prednisone. 25-WEEK MULTI-DRUG PROTOCOL: WEEK 1 – Vincristine 0.5-0.7 mg/m² IV (max 1 mg) + start prednisone 2 mg/kg/day; WEEK 2 – Cyclophosphamide 250 mg/m² PO (with morning furosemide + free water for cystitis prevention); WEEK 3 – Vincristine 0.5-0.7 mg/m² IV; WEEK 4 – Doxorubicin 30 mg/m² IV slow infusion + begin prednisone taper; WEEKS 5-25 – 3-week cycle repeats: vincristine + cyclophosphamide + vincristine + doxorubicin; 5 complete cycles typical. MONITORING: 1) CBC PRE-TREATMENT each visit; 2) Hold if ANC <2000; 3) CBC nadir check (day 7-10 post-treatment); 4) Chemistry every 4-6 weeks; 5) Echocardiogram or ECG before some doxorubicin doses; 6) Cumulative doxorubicin tracking (240 mg/m² limit); 7) Tumor remission assessment at exam + sometimes imaging. OUTCOMES: 1) REMISSION rate 80-90% (complete remission); 2) MEDIAN SURVIVAL 12-14 months from start of treatment; 3) UNTREATED median 2-3 months from diagnosis; 4) Quality of life MAINTAINED through treatment (mild side effects); 5) Some dogs achieve 2-3 year survival with current protocols. RELAPSE handling: 1) Most dogs relapse eventually; 2) MOPP (mechlorethamine + vincristine + procarbazine + prednisone) – rescue protocol; 3) DMAC (dexamethasone + melphalan + actinomycin D + cytarabine); 4) LOMUSTINE single agent; 5) Second remission possible 40-60% of cases. COST: $5000-8000 typically for full 6 months CHOP at general practice; specialty hospital higher; depends on dog size + specific protocol variations. MODIFICATIONS: 1) MADISON-WISCONSIN protocol most common variant; 2) UW-19 (19-week shorter); 3) HOMEY (substituting drugs for severe side effects); 4) MULTI-DRUG protocols for high-risk patients; 5) MAINTENANCE protocols vs no maintenance debate. SIDE EFFECTS typically mild: 1) Brief inappetence 24-48 hr post-treatment; 2) Mild lethargy; 3) Occasional vomiting/diarrhea; 4) Mild neutropenia (CBC monitored); 5) Hair loss UNCOMMON except in Poodles, Bichons, Yorkies, Shih Tzus (continuously growing coats); 6) Doxorubicin cardiotoxicity (monitored); 7) Cyclophosphamide hemorrhagic cystitis (preventable with morning dose + furosemide); 8) Most dogs maintain normal activity through treatment. WORK WITH VETERINARY ONCOLOGIST (Diplomate ACVIM Oncology) – search acvim.org Find a Specialist for optimal outcomes. CHOP HAS TRANSFORMED canine lymphoma from rapidly fatal disease to chronic manageable condition with excellent quality of life for 12-24+ months in many dogs.

What chemotherapy is used for dog osteosarcoma?

CARBOPLATIN is the STANDARD chemotherapy for canine osteosarcoma. TREATMENT PROTOCOL: 1) PRIMARY TREATMENT – AMPUTATION of affected limb (or stereotactic radiosurgery / limb-sparing in select cases); 2) ADJUVANT CHEMOTHERAPY – CARBOPLATIN 250-300 mg/m² IV q3 weeks for 4-6 cycles starting 2-3 weeks after amputation; 3) ALTERNATIVE – DOXORUBICIN 30 mg/m² q3 weeks (used historically; less common now); 4) DOUBLET PROTOCOL – alternating carboplatin and doxorubicin (some specialists). WHY CARBOPLATIN over CISPLATIN: 1) LESS NEPHROTOXIC (kidney damage); 2) NO HYPERHYDRATION requirement (cisplatin requires 18+ hours pre-saline); 3) EQUAL efficacy; 4) BETTER tolerated; 5) NO emetogenic crisis (cisplatin caused severe vomiting); 6) OUTPATIENT administration possible; 7) CISPLATIN largely abandoned in canine oncology. OUTCOMES: 1) AMPUTATION ALONE – median survival 4-5 months (95% die of pulmonary metastasis within year); 2) AMPUTATION + CARBOPLATIN – median survival 10-12 months (some achieve 2+ years); 3) AMPUTATION + DOXORUBICIN – median 8-10 months; 4) LIMB-SPARING SBRT (stereotactic radiosurgery) alternative – similar median survival without amputation; 5) BISPHOSPHONATES (pamidronate, zoledronate) palliative for pain not survival; 6) PALLIATIVE RADIATION 1-3 fractions for pain relief 8-15 weeks. PRESENTATIONS: 1) LARGE BREED dogs (Rottweiler, Great Dane, Mastiff, Newfoundland, Irish Wolfhound, Saint Bernard, Greyhound, German Shepherd, Boxer, Labrador, Golden); 2) Predilection ‘away from elbow toward knee’ – proximal humerus (75%), distal radius (20%), distal femur (large %), proximal tibia (large %); 3) Median age 7-10 years; 4) Sudden lameness + bone pain + sometimes pathologic fracture; 5) ALP often elevated (paraneoplastic). DIAGNOSIS: 1) RADIOGRAPHS show lytic metaphyseal lesion; 2) CT for surgical planning; 3) BIOPSY (Jamshidi needle or open) confirms; 4) THORACIC RADIOGRAPHS for pulmonary metastasis (most dogs have micro-metastases at diagnosis even if rads normal); 5) Sometimes nuclear medicine for skeletal survey. COST: 1) AMPUTATION $2000-4000; 2) CARBOPLATIN 4-6 cycles $3000-6000; 3) TOTAL $5000-10000; 4) LIMB-SPARING SBRT $8000-12000 alternative; 5) ONCOLOGY specialty consultations $200-500; 6) Chemo-related monitoring (CBC, chemistry) $200-500. NEW PROTOCOLS being studied: 1) IMMUNOTHERAPY – Listeria-based osteosarcoma vaccine showing promise but limited availability; 2) TOCERANIB (Palladia) maintenance after chemo; 3) PIROXICAM + chemo combinations; 4) Phase 1/2 clinical trials at specialty hospitals – some offer cutting-edge protocols to research patients. METASTASIS handling: 1) Pulmonary metastasis – poor prognosis once visible on rads; 2) Some dogs respond to second-line chemotherapy; 3) Palliative care for advanced disease; 4) Pain management critical; 5) Quality of life monitoring with Villalobos QoL framework. WORK WITH VETERINARY ONCOLOGIST for optimal outcomes – acvim.org Find a Specialist.

Are there side effects of chemotherapy in dogs?

YES BUT MUCH MILDER than human chemotherapy – critical owner education. CANINE CHEMOTHERAPY SIDE EFFECTS by frequency: 1. COMMON (mild, 25-50% of dogs): a) BRIEF APPETITE DECREASE 24-48 hours post-treatment (maropitant/ondansetron pre-medication helps); b) MILD LETHARGY 24-48 hours; c) Soft stool / occasional diarrhea; d) Mild nausea; 2. MODERATELY COMMON (10-25%): a) Vomiting (1-3 episodes); b) More prolonged diarrhea; c) Mild myelosuppression (asymptomatic neutropenia on CBC); d) Mild appetite loss multiple days; 3. UNCOMMON (5-15%): a) Significant nausea/vomiting requiring treatment; b) Significant diarrhea; c) Neutropenia clinically significant (ANC <2000); d) Mild hair loss in continuously-growing coats (Poodle, Bichon, Yorkie, Shih Tzu, Maltese); e) Mucositis (mouth/throat inflammation); 4. RARE BUT SERIOUS (under 5%): a) FEBRILE NEUTROPENIA – fever during chemo cycle requires hospitalization, antibiotics; b) DOXORUBICIN CARDIOTOXICITY – cumulative dose >240 mg/m² in healthy dogs; 180 mg/m² in DCM-prone breeds; c) CYCLOPHOSPHAMIDE STERILE HEMORRHAGIC CYSTITIS – bloody urine; preventable with morning dose + furosemide + water; d) EXTRAVASATION INJURY (vinca alkaloids, doxorubicin) – tissue necrosis from IV leakage; e) LOMUSTINE HEPATOTOXICITY – cumulative dose damage; f) ANAPHYLAXIS – rare with most agents; doxorubicin requires pre-medication; g) PERMANENT BONE MARROW DAMAGE – very rare. DRUG-SPECIFIC SIDE EFFECTS: 1) DOXORUBICIN – cardiotoxicity cumulative; alopecia in some; allergic reactions; 2) VINCRISTINE – peripheral neuropathy with cumulative; severe extravasation injury; 3) VINBLASTINE – myelosuppression dose-limiting; 4) CYCLOPHOSPHAMIDE – sterile hemorrhagic cystitis preventable; long-term myelosuppression; 5) CARBOPLATIN – nephrotoxic (less than cisplatin); myelosuppression; nausea; 6) CISPLATIN – severe nephrotoxic + vomiting; LARGELY ABANDONED; deadly in cats; 7) LOMUSTINE – hepatotoxic cumulative; delayed nadir day 14; 8) MITOXANTRONE – relatively well-tolerated; blue urine (cosmetic); 9) TOCERANIB (Palladia) – GI side effects most common; proteinuria; hypertension. MANAGEMENT of side effects: 1) PRE-MEDICATION – maropitant (Cerenia) anti-nausea + ondansetron + dexamethasone before doxorubicin; 2) ANTI-EMETICS – maropitant, ondansetron, metoclopramide as needed; 3) APPETITE STIMULANTS – mirtazapine, capromorelin (Entyce); 4) ANTI-DIARRHEAL – metronidazole, probiotics, bland diet; 5) NEUTROPHIL SUPPORT – G-CSF (filgrastim) for severe febrile neutropenia; 6) ANTIBIOTICS – broad-spectrum if febrile neutropenia (cefovecin, amoxicillin-clavulanate, enrofloxacin); 7) FLUID THERAPY – subcutaneous fluids for hydration support; 8) IV CHEMO PROTECTANTS – dexrazoxane for doxorubicin cardioprotection (limited use); 9) DOSE REDUCTION – 20-25% reduction next cycle if significant toxicity. WHEN TO CALL ONCOLOGIST URGENTLY: 1) FEVER above 39.4°C/103°F; 2) Severe vomiting/diarrhea persisting; 3) Inability to eat 48+ hours; 4) Profound lethargy/weakness; 5) Bloody urine (cystitis); 6) Signs of infection; 7) Breathing difficulty; 8) Pale gums or jaundice; 9) Bleeding/bruising; 10) Sudden neurological signs. PREVENTING SEVERE SIDE EFFECTS: 1) CBC pre-treatment EVERY cycle; 2) Chemistry every 4-6 weeks; 3) Cardiac monitoring for doxorubicin; 4) Urinalysis monitoring for cyclophosphamide; 5) Hepatic monitoring for lomustine; 6) Hydration status assessment; 7) Body condition score tracking; 8) Quality of life assessment regular. WORK WITH ONCOLOGIST – dose adjustments + supportive care + protocol modifications to maintain quality of life through treatment. MAJORITY OF DOGS HANDLE CHEMO WELL with quality of life maintained.

How long do dogs live with chemotherapy?

VARIES ENORMOUSLY by cancer type, stage, treatment chosen, and individual response. MEDIAN SURVIVAL with treatment by cancer type: 1. LYMPHOMA – CHOP protocol 12-14 MONTHS median vs untreated 2-3 months; remission 80-90% during treatment; second remission possible 40-60% with rescue protocols. 2. MAST CELL TUMOR (Grade I-II) – 75%+ CURE with wide surgical excision; some require chemo. Grade III high-grade – 12-18 months with surgery + chemo + radiation. 3. OSTEOSARCOMA – amputation + carboplatin chemotherapy 10-12 MONTHS median vs amputation alone 4-5 months vs untreated 1-2 months; 20-30% achieve 2+ years; pulmonary metastasis ultimate cause of death usually. 4. HEMANGIOSARCOMA SPLENIC – splenectomy + doxorubicin 5-7 MONTHS median vs splenectomy alone 3-4 months; I’m-Yunity turkey tail extract may improve modest amount; cardiac form (right atrial) shorter 1-3 months. 5. ANAL SAC ADENOCARCINOMA – sacculectomy + carboplatin/mitoxantrone 18-24 MONTHS median with treatment vs 4-6 months without; lymph node involvement reduces; hypercalcemia paraneoplastic risk. 6. MAMMARY TUMOR – benign tumors EXCELLENT with simple removal; malignant tumors WITHOUT metastasis good 1-2 year median with mastectomy + spay if intact + sometimes chemo; with metastasis poor 4-6 months. 7. TCC BLADDER CANCER – piroxicam alone 6-12 MONTHS median; piroxicam + mitoxantrone 10-12 months; piroxicam + vinblastine 12+ months; rare cures with multi-modal therapy. 8. HISTIOCYTIC SARCOMA (Bernese MD especially) – CCNU lomustine chemotherapy 6-9 months median; aggressive disease; some responses dramatic. 9. ORAL TUMORS – melanoma poor 6-12 months; squamous cell carcinoma good with surgery if early 1-2 years; fibrosarcoma intermediate 1-2 years. 10. SOFT TISSUE SARCOMA – wide excision 1-3 year prognosis depending on grade; recurrence common; rarely metastatic. 11. MULTIPLE MYELOMA – melphalan + prednisone 18-24 MONTHS median; bone pain and lytic lesions managed; hypercalcemia from paraprotein. 12. HEMANGIOSARCOMA CUTANEOUS – excision excellent 1-3 years; visceral form much worse. 13. THYROID CARCINOMA – thyroidectomy excellent if removable 2-3 years; toceranib for unresectable. FACTORS AFFECTING SURVIVAL: 1) STAGE at diagnosis (early vs metastatic); 2) HISTOLOGIC TYPE / GRADE; 3) TREATMENT INTENSITY chosen; 4) PATIENT FACTORS (age, body condition, concurrent disease); 5) RESPONSE TO TREATMENT (complete vs partial remission); 6) COMPLICATIONS during treatment; 7) ABILITY TO TOLERATE protocol completion; 8) ADJUNCTIVE CARE (nutritional, pain management, supportive). QUALITY VS QUANTITY – VETERINARY ONCOLOGY emphasizes QUALITY OF LIFE: 1) Goal NOT cure usually but EXCELLENT quality of life with cancer control; 2) Time gained should be ENJOYABLE for dog; 3) Some clinically appropriate palliative-only treatment legitimate; 4) Owner decision based on quality of life assessment + treatment burden + finances + values. EUTHANASIA decision: 1) Quality of life decline; 2) Treatment burden exceeds benefit; 3) Suffering unmanageable; 4) Villalobos HHHHHMM (7-domain QoL scale); 5) Veterinary oncologist guidance; 6) Hospice care option available many areas; 7) In-home euthanasia services compassionate option. WORK WITH VETERINARY ONCOLOGIST throughout treatment journey for optimal care decisions.

How much does dog chemotherapy cost?

COSTS VARY by cancer type, treatment protocol, location, and specialty vs general practice. TYPICAL COSTS in USA (other countries vary): SIMPLE PROTOCOLS: 1) LYMPHOMA CHOP 25-week protocol $5,000-8,000 typical at general practice; $7,000-12,000 at specialty hospital; 2) MAST CELL TUMOR vinblastine + lomustine protocol $3,000-5,000; 3) MULTIPLE MYELOMA melphalan + prednisone $1,500-3,000/year; 4) INDOLENT LYMPHOMA chlorambucil + prednisone $1,500-2,500/year low cost; 5) PALLIATIVE PIROXICAM-based protocols $30-100/month maintenance. MODERATE PROTOCOLS: 1) OSTEOSARCOMA amputation $2,000-4,000 + carboplatin 4-6 cycles $3,000-6,000 = TOTAL $5,000-10,000; 2) HEMANGIOSARCOMA splenectomy $3,000-6,000 (emergency surgery) + doxorubicin $2,000-4,000 = TOTAL $5,000-10,000; 3) TCC BLADDER piroxicam $40/month + mitoxantrone $3,000-6,000 = TOTAL $3,500-8,000; 4) ANAL SAC ADENOCARCINOMA sacculectomy + lymph node $3,000-6,000 + chemotherapy $3,000-6,000 = TOTAL $6,000-12,000. EXTENSIVE PROTOCOLS: 1) LIMB-SPARING SBRT for osteosarcoma $8,000-12,000; 2) MULTI-MODAL THERAPY (surgery + chemo + radiation) $10,000-20,000+; 3) TARGETED THERAPIES with toceranib (Palladia) $300-500/month; 4) CLINICAL TRIAL TREATMENT – many offer reduced costs or free for research patients. INDIVIDUAL DRUG COSTS at typical practice (per dose at standard BSA): 1) DOXORUBICIN $50-150 + administration; 2) VINCRISTINE $25-75; 3) CYCLOPHOSPHAMIDE $20-50; 4) CARBOPLATIN $150-400; 5) LOMUSTINE $25-50 (capsules); 6) TOCERANIB (Palladia) $4-8 per tablet; 7) MITOXANTRONE $100-250 per dose; 8) MELPHALAN $20-40 monthly. ADDITIONAL COSTS: 1) Initial oncologist consultation $200-500; 2) Imaging – CT $1,500-3,000, MRI $2,000-3,500; 3) Bloodwork between treatments $100-300 each; 4) Hospitalization $500-1,500/day; 5) Supportive care medications (anti-nausea, appetite stimulants) $50-150/month; 6) Recheck examinations $50-200 each; 7) Recheck imaging at intervals $300-1,500. NONPROFIT FINANCIAL ASSISTANCE for dog cancer: 1) REDROVER – redrover.org; 2) PET FUND – thepetfund.com; 3) FRANKIE’S FRIENDS – frankiesfriends.org; 4) MAGIC BULLET FUND – themagicbulletfund.org; 5) BROWN DOG FOUNDATION; 6) BANFIELD CHARITABLE TRUST; 7) Local SPCAs sometimes; 8) Veterinary teaching hospitals reduced costs. PET INSURANCE: 1) Comprehensive plans cover 70-90% of chemo + surgery + diagnostics if obtained PRE-DIAGNOSIS; 2) PRE-EXISTING CONDITIONS EXCLUDED so timing matters; 3) Annual limits vary $5,000-30,000+; 4) Premiums $30-100/month for medium-large dog. FINANCING: 1) CARECREDIT – 6-24 month no-interest financing at most veterinary hospitals; 2) SCRATCHPAY financing; 3) Some hospitals offer in-house payment plans. PALLIATIVE / HOSPICE OPTION ($100-300/month): 1) Pain management; 2) Anti-nausea/appetite stimulants; 3) Supplements (omega-3, turkey tail); 4) Acupuncture; 5) Quality of life monitoring; 6) Veterinary hospice care; 7) In-home euthanasia ($400-700) when time comes. CLINICAL TRIALS – check VeterinarySites.com, ACVIM Forum announcements, Comparative Oncology Trials Consortium for studies enrolling dogs with cancer; often free treatment or significantly reduced cost in exchange for research participation. DISCUSSION WITH ONCOLOGIST upfront about: 1) Realistic costs for proposed protocol; 2) Stage-by-stage payment options; 3) When to reassess if costs problematic; 4) Reduced-intensity protocols vs full protocols; 5) Quality of life vs aggressive treatment; 6) When palliative care more appropriate than active treatment.

Related PuppaDogs Calculators

Continue building your dog’s personalised care plan with these related PuppaDogs calculators:

• Dog Pregnancy / Whelping Due-Date Calculator
• Puppy Weight Predictor (Adult Weight Calculator)
• Heatstroke Risk Calculator for Dogs
• Bloat (GDV) Risk Calculator for Dogs
• Dog Life Expectancy Calculator (Breed, Body Condition, Lifestyle)
• Spay/Neuter Timing Calculator for Dogs (Breed-Specific)

References & Further Reading

The dosing ranges and safety information on this page are drawn from the following veterinary references. Always defer to your own veterinarian and the manufacturer’s label for your specific product.

1. Vail DM et al. Withrow & MacEwen’s Small Animal Clinical Oncology – chemotherapy protocols.
2. Veterinary Cooperative Oncology Group (VCOG) – consensus dosing.
3. ACVIM consensus statement: Lymphoma in dogs.
4. Garrett LD et al. Evaluation of CHOP-based protocols for canine lymphoma. JVIM.
5. Phillips B et al. Modified CHOP protocols (Madison-Wisconsin).
6. Mehlhaff CJ et al. Vincristine 1 mg total cap – rationale and outcomes.
7. Mauldin GN et al. Doxorubicin cardiotoxicity in dogs – cumulative dose limits.
8. Charney VA et al. Cyclophosphamide-induced sterile hemorrhagic cystitis prevention.
9. Selting KA et al. Carboplatin in canine osteosarcoma – meta-analysis.
10. Plumb DC. Plumb’s Veterinary Drug Handbook – canine chemotherapy drugs.
11. Brown DC et al. Effects of Coriolus versicolor (turkey tail) on survival in canine hemangiosarcoma. JVIM 2012.
12. London CA et al. Toceranib (Palladia) – mast cell tumor and other indications.
13. ACVIM Forum – oncology research updates.
14. Find a Specialist – American College of Veterinary Internal Medicine. acvim.org
15. PuppaDogs. Cancer Treatment Cost and Timeline Calculator, Senior Cancer Warning Signs Triage, Mast Cell Tumour Pre-Test Calculator, Lymphoma Pre-Test Calculator. puppadogs.com.

Suyash Dhoot